Barnawi Zhour, Thomas Ronay, Peddinti Radhika, Abou Baker Nabil
Department of Pediatrics, Section of Hematology-Oncology and Bone Marrow Transplant, University of Chicago Medicine, Chicago, IL 60637, USA.
Department of Pediatrics, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
Children (Basel). 2024 Sep 10;11(9):1106. doi: 10.3390/children11091106.
Sickle cell disease (SCD) is the most common hemoglobinopathy in the world. Sickle cell vaso-occlusive episodes (VOEs) are very painful acute events and the most common complication as well as reason for hospitalization. SCD pain is best evaluated holistically with a pain functional assessment to aid in focusing pain management on reducing pain in addition to improving function. Patients with SCD have long endured structural racism and negative implicit bias surrounding the management of pain. Thus, it is important to approach the management of inpatient pain systematically with the use of multi-modal medications and nonpharmacologic treatments. Furthermore, equitable pain management care can be better achieved with standardized pain plans for an entire system and individualized pain plans for patients who fall outside the scope of the standardized pain plans. In this article, we discuss the best practices to manage SCD VOEs during an inpatient hospitalization.
镰状细胞病（SCD）是世界上最常见的血红蛋白病。镰状细胞血管闭塞性发作（VOEs）是非常痛苦的急性事件，也是最常见的并发症以及住院原因。SCD疼痛最好通过疼痛功能评估进行全面评估，以帮助将疼痛管理重点放在减轻疼痛以及改善功能上。SCD患者长期遭受围绕疼痛管理的结构性种族主义和负面隐性偏见。因此，使用多模式药物和非药物治疗系统地处理住院患者的疼痛很重要。此外，通过整个系统的标准化疼痛计划以及针对超出标准化疼痛计划范围的患者的个性化疼痛计划，可以更好地实现公平的疼痛管理护理。在本文中，我们讨论了住院期间管理SCD VOEs的最佳实践。
